Sage Journals: Discover world-class research

Open access

Research article

First published 2021

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

Oliver Illini, Maximilian Johannes Hochmair, Hannah Fabikan [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2020-12

RET,NTRK,ALK,BRAF,and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas

Barbora Pekova, Vlasta Sykorova, Sarka Dvorakova [...]

Thyroid®

Open access

Review article

First published 2023

Advances in the Diagnosis and Treatment of a Driving Target: RET Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China

Tao Li, Wen-Yu Yang, Ting-Ting Liu [...]

Technology in Cancer Research & Treatment

Retricted access

Research article

First published 2009-11

High Iodine Concentration Attenuates RET/PTC3 Oncogene Activation in Thyroid Follicular Cells

Ana Paula Zen Petisco Fiore, Cesar Seigi Fuziwara, Edna Teruko Kimura

Thyroid®

Retricted access

Research article

First published 2024-08

An Ensemble AI Model for RET Alteration Detection Using H&E Images as a Putative Screening Tool for More Efficient Genomic Alteration Detection

Krishna Bairavi, Bobak Kechavarzi, Arkan Abadi [...]

AI in Precision Oncology

Free access

Other

First published 2019-11

CCDC6,a gene product in fusion with different protoncogenes,as a potential chemotherapeutic target

Aishwarya Laxmi, Pawan Gupta, Jeena Gupta

Cancer Biomarkers

Retricted access

Research article

First published 2017-06

Identification of Three Novel Fusion Oncogenes,SQSTM1/NTRK3,AFAP1L2/RET,and PPFIBP2/RET,in Thyroid Cancers of Young Patients in Fukushima

Keita Iyama, Michiko Matsuse, Norisato Mitsutake [...]

Thyroid®

Open access

Case report

First published 2020-09

Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid Carcinoma

Dora Dias-Santagata, Jochen K. Lennerz, Peter M. Sadow [...]

Thyroid®

Retricted access

Research article

First published 2014-02

Effects of Silencing the RET/PTC1 Oncogene in Papillary Thyroid Carcinoma by siRNA-Squalene Nanoparticles With and Without Fusogenic Companion GALA-Cholesterol

Hafiz Muhammad Ali, Andrei Maksimenko, Giorgia Urbinati [...]

Thyroid®

Retricted access

Case report

First published 2026

Central nervous system effectiveness of selpercatinib retreatment in heavily pretreated NSCLC patient with RET rearrangement: A case report

Margherita Agostini, Samuele Compagno, Francesca Sperandi [...]

Tumori Journal

Search results